W. A. Lee

发表

Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.

Y. J. Wang, T. Patapoff, B. Narog, 1991, Journal of pharmaceutical sciences.

1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo

Z. H. Li, K. Kent, D. Mendel, 1994, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.

J. Shaw, L. Griffin, K. Cundy, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.

William A. Lee, P. Tellier, K. Cundy, 1998, Toxicological sciences : an official journal of the Society of Toxicology.

Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.

J. Shaw, K. Cundy, M. Hitchcock, 1996, Current eye research.

Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.

J. Shaw, V. Krishnamurthy, K. Cundy, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Bioavailability and metabolism of cidofovir following topical administration to rabbits.

K. Cundy, W. A. Lee, G. Lynch, 1997, Antiviral research.

Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.

J. Shaw, G. Visor, C. Nakamura, 1997, Journal of pharmaceutical sciences.

Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys

J. Shaw, K. Cundy, W. A. Lee, 1994, Antimicrobial Agents and Chemotherapy.

Optimization of in vitro flux through hairless mouse skin of cidofovir, a potent nucleotide analog.

R. Guy, J. Kennedy, E. Aspé, 1995, Journal of pharmaceutical sciences.

Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.

Z. H. Li, K. Cundy, W. A. Lee, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug.

Z. H. Li, K. Cundy, M. Hitchcock, 1996, Drug Metabolism And Disposition.

Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir.

R. Oliyai, G. Visor, W. A. Lee, 1999, International journal of pharmaceutics.

The application of size exclusion chromatography and computer simulation to study the thermodynamic and kinetic parameters for short-lived dissociable protein aggregates.

R. Mrsny, T. Patapoff, W. A. Lee, 1993, Analytical biochemistry.